+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Wearable Injectors - Global Market Trajectory & Analytics

  • ID: 4806322
  • Report
  • April 2021
  • Region: Global
  • Global Industry Analysts, Inc

FEATURED COMPANIES

  • Amgen, Inc.
  • Bespak Europe Ltd.
  • Enable Injections, Inc.
  • Insulet Corporation
  • Medtronic PLC
  • Sensile Medical AG
Global Wearable Injectors Market to Reach $9.2 Billion by 2027

Amid the COVID-19 crisis, the global market for Wearable Injectors estimated at US$4.8 Billion in the year 2020, is projected to reach a revised size of US$9.2 Billion by 2027, growing at a CAGR of 9.7% over the period 2020-2027. On-Body injectors, one of the segments analyzed in the report, is projected to record 9.5% CAGR and reach US$6.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Off-Body injectors segment is readjusted to a revised 10.2% CAGR for the next 7-year period.



The U.S. Market is Estimated at $1.4 Billion, While China is Forecast to Grow at 9.1% CAGR

The Wearable Injectors market in the U.S. is estimated at US$1.4 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2027 trailing a CAGR of 9.1% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 9% and 7.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.

Select Competitors (Total 43 Featured):
  • Amgen, Inc.
  • Becton, Dickinson and Company
  • Bespak Europe Ltd.
  • Enable Injections, Inc.
  • Insulet Corporation
  • Medtronic PLC
  • Sensile Medical AG
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Valeritas, Inc.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Amgen, Inc.
  • Bespak Europe Ltd.
  • Enable Injections, Inc.
  • Insulet Corporation
  • Medtronic PLC
  • Sensile Medical AG
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Current & Future Analysis for Wearable Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 2: World 7-Year Perspective for Wearable Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2020 & 2027
  • Table 3: World Current & Future Analysis for On-Body injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 4: World 7-Year Perspective for On-Body injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 5: World Current & Future Analysis for Off-Body injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 6: World 7-Year Perspective for Off-Body injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 7: World Current & Future Analysis for Immuno-oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 8: World 7-Year Perspective for Immuno-oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 9: World Current & Future Analysis for Diabetes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 10: World 7-Year Perspective for Diabetes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 11: World Current & Future Analysis for Other Therapies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 12: World 7-Year Perspective for Other Therapies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 13: World Current & Future Analysis for Spring Based by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 14: World 7-Year Perspective for Spring Based by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 15: World Current & Future Analysis for Motor Driven by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 16: World 7-Year Perspective for Motor Driven by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 17: World Current & Future Analysis for Rotary Pump by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 18: World 7-Year Perspective for Rotary Pump by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 19: World Current & Future Analysis for Battery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 20: World 7-Year Perspective for Battery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 21: World Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 22: World 7-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 23: World Current & Future Analysis for Semi-Reusable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 24: World 7-Year Perspective for Semi-Reusable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
  • Table 25: World Current & Future Analysis for Disposable by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 26: World 7-Year Perspective for Disposable by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2020 & 2027
III. MARKET ANALYSIS
  • UNITED STATES
  • Table 27: USA Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 28: USA 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 29: USA Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 30: USA 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 31: USA Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 32: USA 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 33: USA Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 34: USA 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
  • CANADA
  • Table 35: Canada Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 36: Canada 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 37: Canada Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 38: Canada 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 39: Canada Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 40: Canada 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 41: Canada Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 42: Canada 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
  • JAPAN
  • Table 43: Japan Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 44: Japan 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 45: Japan Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 46: Japan 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 47: Japan Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 48: Japan 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 49: Japan Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 50: Japan 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
  • CHINA
  • Table 51: China Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 52: China 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 53: China Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 54: China 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 55: China Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 56: China 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 57: China Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 58: China 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
  • EUROPE
  • Table 59: Europe Current & Future Analysis for Wearable Injectors by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
  • Table 60: Europe 7-Year Perspective for Wearable Injectors by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2020 & 2027
  • Table 61: Europe Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 62: Europe 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 63: Europe Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 64: Europe 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 65: Europe Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 66: Europe 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 67: Europe Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 68: Europe 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
  • FRANCE
  • Table 69: France Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 70: France 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 71: France Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 72: France 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 73: France Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 74: France 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 75: France Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 76: France 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
  • GERMANY
  • Table 77: Germany Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 78: Germany 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 79: Germany Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 80: Germany 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 81: Germany Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 82: Germany 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 83: Germany Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 84: Germany 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
  • ITALY
  • Table 85: Italy Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 86: Italy 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 87: Italy Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 88: Italy 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 89: Italy Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 90: Italy 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 91: Italy Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 92: Italy 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
  • UNITED KINGDOM
  • Table 93: UK Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 94: UK 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 95: UK Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 96: UK 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 97: UK Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 98: UK 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 99: UK Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 100: UK 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
  • REST OF EUROPE
  • Table 101: Rest of Europe Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 102: Rest of Europe 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 103: Rest of Europe Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 104: Rest of Europe 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 105: Rest of Europe Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 106: Rest of Europe 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 107: Rest of Europe Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 108: Rest of Europe 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
  • ASIA-PACIFIC
  • Table 109: Asia-Pacific Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 110: Asia-Pacific 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 111: Asia-Pacific Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 112: Asia-Pacific 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 113: Asia-Pacific Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 114: Asia-Pacific 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 115: Asia-Pacific Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 116: Asia-Pacific 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
  • REST OF WORLD
  • Table 117: Rest of World Current & Future Analysis for Wearable Injectors by Type - On-Body injectors and Off-Body injectors - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 118: Rest of World 7-Year Perspective for Wearable Injectors by Type - Percentage Breakdown of Value Sales for On-Body injectors and Off-Body injectors for the Years 2020 & 2027
  • Table 119: Rest of World Current & Future Analysis for Wearable Injectors by Therapy - Immuno-oncology, Diabetes and Other Therapies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 120: Rest of World 7-Year Perspective for Wearable Injectors by Therapy - Percentage Breakdown of Value Sales for Immuno-oncology, Diabetes and Other Therapies for the Years 2020 & 2027
  • Table 121: Rest of World Current & Future Analysis for Wearable Injectors by Technology - Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 122: Rest of World 7-Year Perspective for Wearable Injectors by Technology - Percentage Breakdown of Value Sales for Spring Based, Motor Driven, Rotary Pump, Battery and Other Technologies for the Years 2020 & 2027
  • Table 123: Rest of World Current & Future Analysis for Wearable Injectors by Usage - Semi-Reusable and Disposable - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
  • Table 124: Rest of World 7-Year Perspective for Wearable Injectors by Usage - Percentage Breakdown of Value Sales for Semi-Reusable and Disposable for the Years 2020 & 2027
IV. COMPETITION
  • Total Companies Profiled: 43
Note: Product cover images may vary from those shown
  • Amgen, Inc.
  • Becton, Dickinson and Company
  • Bespak Europe Ltd.
  • Enable Injections, Inc.
  • Insulet Corporation
  • Medtronic PLC
  • Sensile Medical AG
  • Tandem Diabetes Care, Inc.
  • United Therapeutics Corporation
  • Valeritas, Inc.
Note: Product cover images may vary from those shown
Adroll
adroll